U.S. Physical Therapy (NYSE:USPH – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.76 by $0.04, Zacks reports. U.S. Physical Therapy had a net margin of 3.97% and a return on equity of 9.39%.
U.S. Physical Therapy Stock Performance
USPH stock traded up $4.92 on Wednesday, reaching $89.66. 282,638 shares of the company were exchanged, compared to its average volume of 204,873. The firm has a market capitalization of $1.34 billion, a PE ratio of 527.45, a PEG ratio of 2.16 and a beta of 1.16. U.S. Physical Therapy has a 12 month low of $58.19 and a 12 month high of $90.94. The stock’s fifty day moving average price is $83.16 and its 200 day moving average price is $76.91. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the company. Citigroup reiterated a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Wednesday, August 19th. Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. Barrington Research upped their price objective on shares of U.S. Physical Therapy from $90.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, August 10th. Finally, JPMorgan Chase & Co. lifted their target price on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, September 11th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, U.S. Physical Therapy has an average rating of “Moderate Buy” and a consensus price target of $98.25.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.
In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.
Featured Articles
- Five stocks we like better than U.S. Physical Therapy
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
